CASTLE PARTNERSHIP — All Prescriptions & Medications — Page 9
Practice Code: D82011 | NORWICH, NR3 1SE
Showing results 401-450 of 697
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hyoscine hydrobromide | 56 | 2,302 | £374 | +64.0% ▲ |
| Levodopa/carbidopa/entacapone | 56 | 6,774 | £4.5K | +100.3% ▲ |
| Powder 1.5 kcal/ml smoothie plant based (0913011) | 56 | 922 | £923 | +419.0% ▲ |
| 56 | 2,402 | £4.1K | +204.2% ▲ | |
| Clonidine hydrochloride | 55 | 3,675 | £286 | +201.1% ▲ |
| Celecoxib | 55 | 1,972 | £132 | -16.7% ▼ |
| 55 | 223 | £539 | +69.7% ▲ | |
| 55 | 6,180 | £10.4K | +159.8% ▲ | |
| Olmesartan medoxomil | 54 | 1,576 | £56 | -21.6% ▼ |
| Domperidone | 54 | 4,767 | £103 | +51.4% ▲ |
| Nefopam hydrochloride | 54 | 4,911 | £203 | -52.3% ▼ |
| Buprenorphine hydrochloride | 54 | 738 | £1.4K | -91.4% ▼ |
| Estradiol valerate | 53 | 4,200 | £351 | +171.4% ▲ |
| 53 | 1,040 | £124 | +97.3% ▲ | |
| 53 | 3,360 | £2.4K | +60.3% ▲ | |
| Rabeprazole sodium | 52 | 2,856 | £323 | +0.8% vs avg |
| Chlordiazepoxide hydrochloride | 52 | 1,092 | £140 | +259.0% ▲ |
| Triptorelin acetate | 52 | 52 | £3.4K | +262.7% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 52 | 5,118 | £3.4K | +95.8% ▲ |
| Mefenamic acid | 52 | 2,621 | £519 | +15.1% ▲ |
| Glycerol | 51 | 868 | £139 | +45.4% ▲ |
| Azelaic acid | 51 | 1,740 | £370 | +113.3% ▲ |
| 51 | 6,303 | £10.8K | +27.9% ▲ | |
| 51 | 25.5K | £1.7K | +33.8% ▲ | |
| Buspirone hydrochloride | 50 | 4,288 | £535 | -0.8% vs avg |
| Rasagiline mesilate | 50 | 1,386 | £1.5K | +34.6% ▲ |
| Alprostadil | 50 | 289 | £3.8K | +192.4% ▲ |
| Colesevelam hydrochloride | 49 | 9,720 | £3.9K | +29.1% ▲ |
| 48 | 2,232 | £4.2K | +170.6% ▲ | |
| Tafluprost | 47 | 834 | £625 | +153.5% ▲ |
| Fenofibrate | 46 | 1,510 | £170 | -52.5% ▼ |
| Dabigatran etexilate | 45 | 3,248 | £2.6K | -13.1% ▼ |
| Urea | 45 | 13.2K | £647 | -32.7% ▼ |
| 45 | 2,545 | £4.5K | +33.2% ▲ | |
| Budesonide | 44 | 3,419 | £2.8K | +180.8% ▲ |
| Medroxyprogesterone acetate | 44 | 3,067 | £512 | +15.0% ▲ |
| 44 | 112 | £459 | +41.9% ▲ | |
| 44 | 1,220 | £6.3K | +97.2% ▲ | |
| 43 | 4,900 | £338 | -49.5% ▼ | |
| 43 | 106 | £700 | +54.5% ▲ | |
| Aciclovir | 42 | 270 | £257 | +240.7% ▲ |
| Indacaterol/glycopyrronium | 41 | 1,230 | £1.3K | -9.2% ▼ |
| Ibandronic acid | 41 | 507 | £510 | +12.8% ▲ |
| Etonogestrel | 41 | 41 | £3.4K | +41.8% ▲ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 41 | 102.0K | £1.8K | +7.4% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 41 | 195.4K | £3.8K | -41.4% ▼ |
| Olopatadine | 41 | 265 | £248 | -6.5% ▼ |
| Tacrolimus | 41 | 1,800 | £1.4K | -24.0% ▼ |
| Other individually formulated bought in preparations | 41 | 1,749 | £609 | +25.5% ▲ |
| Nebivolol | 40 | 1,400 | £294 | -62.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.